| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T199 |
0-72 |
Sentence |
denotes |
Nutritional Sources, Availability and Uses for Lactoferrin as Supplement |
| T200 |
73-140 |
Sentence |
denotes |
There is considerable LF availability in various forms and sources. |
| T201 |
141-257 |
Sentence |
denotes |
Table 3 shows some of the sources and the references to research where it has been used to treat various conditions. |
| T202 |
258-367 |
Sentence |
denotes |
Table 3 Lactoferrin sources as supplements, and examples where it has been used to treat various conditions. |
| T203 |
368-402 |
Sentence |
denotes |
Lactoferrin sources as supplements |
| T204 |
403-423 |
Sentence |
denotes |
Product References |
| T205 |
424-568 |
Sentence |
denotes |
Bovine and human milk Morinaga Industries in Japan (183) DoMO Food Ingredients, a subsidiary of Friesland Dairy Foods, in the Netherlands (184) |
| T206 |
569-659 |
Sentence |
denotes |
Human recombinant lactoferrin Talactoferrin from Agennix, Inc., Houston, Texas, USA (184) |
| T207 |
660-758 |
Sentence |
denotes |
Lactoferrin expression in transgenic rice Ventrus Biosciences, New York City, New York, USA (184) |
| T208 |
759-817 |
Sentence |
denotes |
Transgenic cattle expressing human lactoferrin (185, 186) |
| T209 |
818-889 |
Sentence |
denotes |
Transgenic maize Meristem therapeutics, Clermont-Ferrand, France (184) |
| T210 |
890-950 |
Sentence |
denotes |
Lactoferrin supplementation in treatment of various diseases |
| T211 |
951-1041 |
Sentence |
denotes |
Might be useful in treating sepsis or necrotizing enterocolitis in preterm neonates (184) |
| T212 |
1042-1075 |
Sentence |
denotes |
Support for vaginal health (187) |
| T213 |
1076-1273 |
Sentence |
denotes |
LF may play a protective role in host defense against SARS-CoV infection through binding to HSPGs and blocking the preliminary interaction between SARS-CoV and host cells (cell culture study) (99) |
| T214 |
1274-1447 |
Sentence |
denotes |
LF is a modulator of innate immune responses in the urinary tract and has potential application in novel therapeutic design for urinary tract infection (animal study) (188) |
| T215 |
1448-1530 |
Sentence |
denotes |
Possible therapy against Candida albicans in the oral cavity (a hypothesis) (189) |
| T216 |
1531-1599 |
Sentence |
denotes |
Protection against Chlamydia trachomatis (cell culture study) (190) |
| T217 |
1600-1667 |
Sentence |
denotes |
Treatment of taste and smell abnormalities after chemotherapy (52) |
| T218 |
1668-1741 |
Sentence |
denotes |
LF supplements and food with high levels of LF for oral health (99, 191) |
| T219 |
1742-1838 |
Sentence |
denotes |
LF treatment of black stain associated with of iron metabolism disorders with lactoferrin (192) |
| T220 |
1839-2005 |
Sentence |
denotes |
Aerosolized bovine LF counteracts infection, inflammation and iron dysbalance in a cystic fibrosis mouse model of Pseudomonas aeruginosa chronic lung infection (193) |
| T221 |
2006-2043 |
Sentence |
denotes |
LF inhalations for lung health (194) |
| T222 |
2044-2079 |
Sentence |
denotes |
LF for optimal skin moisture (195) |
